Procedures for the inactivation of viruses in clotting factor concentrates
- 1 November 1986
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 23 (3), 295-305
- https://doi.org/10.1002/ajh.2830230315
Abstract
Click on the article title to read more.Keywords
This publication has 20 references indexed in Scilit:
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesTransfusion, 1985
- CASE FOR CONCLUDING THAT HEAT-TREATED, LICENSED ANTI-HAEMOPHILIC FACTOR IS FREE FROM HTLV-IIIThe Lancet, 1985
- WET HEATING FOR SAFER FACTOR VIII CONCENTRATE?The Lancet, 1985
- Coincidental Appearance of LAV/HTLV-III Antibodies in Hemophiliacs and the Onset of the AIDS EpidemicNew England Journal of Medicine, 1985
- NON FACTOR VIII RELATED CONSTITUENTS IN CONCENTRATESScandinavian Journal of Haematology, 1984
- Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndromeJAMA, 1984
- Inactivation of Non‐A, Non‐B Virus Infectivity by a Beta Propiolactone/Ultraviolet Irradiation Treatment and Aerosil Adsorption Procedure Used for Preparation of a Stabilized Human SerumVox Sanguinis, 1984
- Hepatocellular enzyme patterns and hepatitis b virus exposure in multitransfused young and very young hemophilia patientsAmerican Journal of Hematology, 1981